ArticleBrain sciences2021

Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker GPSM3 in Low-Grade Gliomas.

Ming Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.